Related Experiment Videos
E1AF degradation by a ubiquitin-proteasome pathway.
Akiko Takahashi1, Fumihiro Higashino, Mariko Aoyagi
1Department of Oral Pathobiological Science, Hokkaido University Graduate School of Dental Medicine, North 13 West 7, Kita-ku 060-8586, Sapporo, Japan.
Biochemical and Biophysical Research Communications
|January 5, 2005
Summary
The ETS transcription factor E1AF is degraded through the ubiquitin-proteasome pathway. Inhibiting this pathway stabilizes E1AF protein, impacting its function in mammary tumors.
Area of Science:
- Molecular Biology
- Cancer Research
- Cellular Biology
Background:
- E1AF, an ETS family transcription factor, is overexpressed in mammary tumors, correlating with tumorigenesis.
- However, E1AF protein levels are typically low, and its degradation mechanism remains unclear.
Purpose of the Study:
- To investigate the degradation mechanism of E1AF protein.
- To understand the role of the ubiquitin-proteasome pathway in E1AF regulation.
Main Methods:
- Treatment of cells with the 26S protease inhibitor MG132.
- Analysis of E1AF ubiquitination via its C-terminal region.
- Observation of ubiquitinated E1AF localization in nuclear dots.
- Assessment of proteasome inhibition on E1AF target promoter activity.
Main Results:
- MG132 treatment stabilized E1AF protein, indicating proteasomal degradation.
- E1AF undergoes ubiquitination, primarily in its C-terminal region.
- Ubiquitinated E1AF forms aggregates within nuclear dots.
- Inhibition of the proteasome affects E1AF-mediated transcription.
Conclusions:
- E1AF protein is degraded via the ubiquitin-proteasome pathway.
- This degradation mechanism influences E1AF's transcriptional activity and function.